
Walmart settles federal opioid case over pharmacy dispensing
Walmart has settled a federal lawsuit accusing its pharmacies of violating the Controlled Substances Act by unlawfully dispensing opioids; terms are undisclosed and the case was dismissed by stipulation in Delaware. The settlement ends a high-profile DOJ case tied to the opioid epidemic, following Walmart's 2022 $3.1 billion deal to resolve related claims.













